Universitätsklinikum Düsseldorf

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. (2025) Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML (2025) Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, Steffen B, Kaufmann M, Burchert A, et al. Journal article Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis (2025) Li YN, Filla T, Györfi AH, Liang M, Devakumar V, Micu A, Chai H, et al. Journal article Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System—A Multicenter Cohort Study in 163 Patients (2025) Fisse AL, Bonberg N, Beuker C, Pfeuffer C, Heidenreich A, Krüger C, Deb-Chatterji M, et al. Journal article S3-Leitlinie Nierenersatztherapie in der Intensivmedizin: Evidenzbasierte Durchführung der Nierenersatztherapie bei kritisch Kranken (2025) Willam C, Abu-Tair M, Bayer M, Bellmann R, Brunkhorst F, Custodis F, Galle J, et al. Journal article Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis (2025) Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, Weber S, et al. Journal article Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research—An interdisciplinary prospective survey among the young workforce (2025) Trommer M, Grohmann M, Fabian A, Ehret F, Hess J, Rückert M, Matschke J, et al. Journal article Antifibrotic effects of specific targeting of the 5-hydroxytryptamine 2B receptor (5-HT2BR) in murine models and ex vivo models of scleroderma skin (2025) Trinh-Minh T, Tran-Manh C, Györfi AH, Dickel N, Liebel C, Zhou X, Wang J, et al. Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article